Parkinson

Israeli man facing early-onset Alzheimer's develops potential treatment for Parkinson's disease

Initially turned away, Ofer Shina built X-tosis around Prof. Varda Shoshan-Barmatz's research. The startup has a $2.74 million Michael J. Fox Foundation grant and is initially targeting Parkinson's.

Prof. Varda Shoshan-Barmatz in her lab at Ben-Gurion University of the Negev, where her research on the protein VDAC1 led to the founding of X-tosis.
 Alan Greenspan.

Alan Greenspan, Jewish economist, longtime head of Federal Reserve, dies at 100

Making Parkinson's cure personal: TechBio co-founder Micha Breakstoneand developmental biologist Olivier Pourquie.

AI meets biology: How cellular intelligence is redefining stem cell therapy

In this photo illustration, a smartphone displays the logo of Novo Nordisk (NYSE: NVO), a Denmark-based pharmaceutical company specializing in diabetes care, obesity treatment, in front of a screen showing the company's latest stock market chart, January 29, 2026

Cellular Intelligence strikes deal with Novo Nordisk to advance Parkinson’s cell therapy


Hebrew University develops method to diagnose early-stage Parkinson’s disease

30,000 Israelis and 10 million people worldwide live with the disorder.

 MRI images used for automatic detection of microstructural changes in early-stage Parkinson’s Disease (PD) patients. Marked in yellow are areas in the putamen where PD patients show tissue damage, compared to healthy controls.

Possible cause of long COVID ‘brain fog’ revealed - study

In the course of their research, scientists found that the neurological effects of long-COVID were strikingly similar to Alzheimer's and Parkinson's.

 A healthy brain compared to a brain suffering from Alzheimer's Disease

Israeli scientists solve mystery: How human brain processes, stores movement

Technion-Israel Institute of Technology scientists found that computation occurs not just in the interaction among nerve cells but also within each individual neuron. 

 Three pyramidal nerve cells in the motor cortex, whose job it is to send the motor commands directly to the spinal cord. The cells are characterized by a pyramidal shape of the cell bodies and highly branched dendritic trees, a feature that allows them to perform complex parallel processing.

Israeli study on neural activity could lead to treatment for Alzheimer's disease

How exactly do brain waves transmit information, and what can this mean for the connection between decreased brain activity and neurodegenerative diseases?

 A healthy brain compared to a brain suffering from Alzheimer's Disease

In Parkinson's Awareness Month, Parkinson's pioneer wins Israel Prize

Technion Prof. Emeritus Moussa Youdim was among the first to identify the genes that are changed in the brains of people with Parkinson’s disease.

 ISRAEL PRIZE winner Prof. Moussa Youdim has developed drugs for neurodegenerative diseases.

Israeli Parkinson's treatment shows positive results, eyes FDA approval

P2B001 is a fixed-dose combination of extended-release formulations of pramipexole and rasagiline.  

 Parkinson's disease (illustrative)

Israeli man finds creative way to raise awareness on unprofitable drugs

When Dan Vesely was diagnosed with Parkinson's, he had to do his own research, which involved manipulating the system that leaves many without an option.

Generic regular strength enteric coated 325mg aspirin tablets, distributed by Target Corporation.

3 ways to know if your Parkinson’s disease is advancing 

Do you have Parkinson's? There are three signs that the disease is progressing. Here’s how to manage them.

 Parkinson's disease (illustrative)

Australian researchers develop hydrogel to combat Parkinson's

A gel made of amino acids can be used to treat symptoms of Parkinson's disease - Australian National University researchers

 Professor David Nisbet from Australian National University (ANU) holds a vial as researchers from ANU developed a new type of hydrogel that could help to defeat Parkinson's disease, in this undated handout picture.

Can studying the origins of Parkinson's help treat it? - study

New research from Hebrew University and Penn State analyzes the shapes a specific protein found in neurons takes as the disease develops.

Researchers from Hebrew University and Penn State College of Medicine teamed up to study the different conformations of a protein called alpha-synuclein, which when combined to form harmful aggregates, may lead to the development of neurodegenerative diseases.